Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on the Receipt of Clinical Trial Approval Notice for Qingrun Yangmu Granules

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Receipt of Clinical Trial Approval Notice for Qingrun Yangmu Granules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment